Novugen Pharma (Malaysia) Sdn Bhd

General

Total Cases1

Active Cases1

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
08/13/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	Official Transcript of Oral Argument held on 08/09/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/3/2024. Redacted Transcript Deadline set for 9/13/2024. Release of Transcript Restriction set for 11/12/2024. (Triozzi, Heather) (Entered: 08/13/2024) Official Transcript of Oral Argument held on 08/09/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/3/2024. Redacted Transcript Deadline set for 9/13/2024. Release of Transcript Restriction set for 11/12/2024. (Triozzi, Heather) (Entered: 08/13/2024)
08/13/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 434 Notice of Appeal (Federal Circuit), filed by Novartis Pharmaceuticals Corporation. USCA Case Number 2024-2210 (nms) (Entered: 08/13/2024)
08/13/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 434 Notice of Appeal (Federal Circuit) filed by Novartis Pharmaceuticals Corporation. USCA Case Number 2024-2209 (nms) (Entered: 08/13/2024)
08/13/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 434 Notice of Appeal (Federal Circuit). (oam) (Entered: 08/13/2024)
08/13/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	Notification regarding 434 Notice of Appeal (Federal Circuit) sent to Reporter Triozzi (oam) (Entered: 08/13/2024)
08/13/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	Notification regarding 434 Notice of Appeal (Federal Circuit) sent to Reporter Warner (oam) (Entered: 08/13/2024)
08/12/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	NOTICE OF APPEAL to the Federal Circuit of 433 Memorandum and Order,,, . Appeal filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 08/12/2024)
08/12/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	NOTICE OF APPEAL to the Federal Circuit of 433 Memorandum and Order. Appeal filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 8/13/2024 (nms). (Entered: 08/12/2024)
08/12/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	MEMORANDUM ORDER: Novartis's motion for an injunction pending appeal (D.I. 421 in 19-cv-2053-RGA; DI. 1432 in 20-md-2930-RGA) is DENIED. I will grant Novartis's request for a stay (id) to allow Novartis to seek injunctive relief from the Federal Circuit. I expect Novartis to appeal this Memorandum Order by filing a notice of appeal today. I further expect Novartis to file emergency motions in the Court of Appeals as soon as possible. With that understanding, Novartis and MSN are hereby ordered to maintain the status quo for 72 hours from the issuance of this Memorandum Order. I expect the Court of Appeals is in the best position to decide whether to continue the stay, and, if it does, for how long. Signed by Judge Richard G. Andrews on 8/12/2024. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-02053-RGA(nms) (Entered: 08/12/2024) MEMORANDUM ORDER: Novartis's motion for an injunction pending appeal (D.I. 421 in 19-cv-2053-RGA; DI. 1432 in 20-md-2930-RGA) is DENIED. I will grant Novartis's request for a stay (id) to allow Novartis to seek injunctive relief from the Federal Circuit. I expect Novartis to appeal this Memorandum Order by filing a notice of appeal today. I further expect Novartis to file emergency motions in the Court of Appeals as soon as possible. With that understanding, Novartis and MSN are hereby ordered to maintain the status quo for 72 hours from the issuance of this Memorandum Order. I expect the Court of Appeals is in the best position to decide whether to continue the stay, and, if it does, for how long. Signed by Judge Richard G. Andrews on 8/12/2024. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-02053-RGA(nms) (Entered: 08/12/2024)
08/12/24	Novartis Pharmaceuticals Corp v. Hetero USA Inc 1:19-CV-02053 ( D. DE )	APPEAL - Credit Card Payment received re 434 Notice of Appeal (Federal Circuit) filed by Novartis Pharmaceuticals Corporation. ( Filing fee $605, receipt number ADEDC-4474131.) (Silver, Daniel) (Entered: 08/12/2024)